HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
PDF Library
RSS Feeds
Subscribe
FAQs
Advertising
Partnered Content
Report Store
UsernamePublicRestriction
Tags:
Digital Health Innovation Personalized Medicine

Sanofi Personalizing IBS Treatment With Digital Therapy

  • News

Executive Summary

Sanofi Consumer Healthcare has teamed up with digital health player Cara Care to offer an innovative treatment for IBS which goes beyond the pill and helps sufferers access personalized support for their illness.

You may also be interested in...



UK Marketing: Sanofi Launches Buscomint, New Releases From Salonpas and Nailner

The latest OTC launches in the UK, including Buscomint from Sanofi, Salonpas Gel-Patch from Hisamitsu and Nailner Active Cover from Karo.

Sanofi Tapping AI To Help Consumers Manage IBS

Sanofi is utilizing AI technology to help UK consumers to better manage their IBS and digestive symptoms. 

What A Relief! Three German IBS Launches From Sanofi, Dr Kade, Dr Loges

Sanofi on trend with plant-based, app-supported Buscopan line extension, Dr Kade offers all-in-one gastrointestinal product and Dr Loges appeals to children with blueberry flavored supplement. 

Table

View full table

Related Content

HBW Insight
HBW Insight
HBW Insight
HBW Insight
HBW Insight

Topics

Related Companies

Tags:
Digital Health Innovation Personalized Medicine
UsernamePublicRestriction

Register

MT142464

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By